IRIDEX (IRIX) vs Lifeward (LFWD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IRIDEX (IRIX) has outperformed Lifeward (LFWD) over the past year, losing 17.6% versus a loss of 35.3%. Over five years, IRIX leads with a -87.9% price change compared with -94.4% for LFWD. Lifeward is the larger company by market cap ($18.2 million vs $15.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IRIX | LFWD |
|---|---|---|
| Share price | $0.898 | $6.43 |
| Market cap | $15.77M | $18.21M |
| 1-day change | +2.24% | -1.08% |
| YTD return | -21.23% | -7.13% |
| 1-year return | -17.61% | -35.29% |
| 5-year return | -87.88% | -94.37% |
| EPS (TTM) | $-0.20 | $-15.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.65 | $9.84 |
| 52-week low | $0.61 | $4.14 |
| Distance from 52-week high | -45.58% | -34.65% |
| Analyst consensus | none | none |
| Avg. price target upside | +206.24% | +211.04% |
| Average volume | 389.24K | 6.08K |
| Shares outstanding | 17.56M | 2.83M |
| Employees | 93 | 81 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IRIX has outperformed LFWD by 17.7 percentage points over the past year.
About IRIDEX
IRIX stock →IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.
Healthcare · Medical Devices · 93 employees
About Lifeward
LFWD stock →Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke.
Healthcare · Medical Devices · 81 employees
IRIX vs LFWD FAQ
Which is bigger, IRIDEX or Lifeward?
Lifeward (LFWD) is larger, with a market capitalization of $18.21M compared with $15.77M for IRIDEX (IRIX).
Which stock has performed better over the past year, IRIX or LFWD?
IRIX returned -17.61% over the past 12 months, compared with -35.29% for LFWD (price return, excluding dividends). Past performance does not predict future results.
Are IRIDEX and Lifeward in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.